key: cord-0991132-mlk7k7b8 authors: Yao, Yangcheng; Yuan, Xiaoqiong; Wu, Linjing; Guo, Na; Yin, Li; Li, Yufeng title: COVID‐19 and male reproduction: Current research and unknown factors date: 2021-02-01 journal: Andrology DOI: 10.1111/andr.12970 sha: 33899db99650d62aa65a9ec9cfe4690918c0374d doc_id: 991132 cord_uid: mlk7k7b8 BACKGROUND: The testes are suspected target organs of SARS‐CoV‐2. However, the results of studies on the effect of COVID‐19 on male reproduction are controversial. OBJECTIVE: To summarize current research on the effects of COVID‐19 on male reproduction. METHODS: A systematic review of English literature was performed using PubMed and Ovid Embase up to 18 August 2020. Research articles on the presence of SARS‐CoV‐2 in semen, the effects of the virus on semen parameters and any pathological changes in the testes were evaluated. RESULTS: Fourteen studies were included in this review. Six of 176 survivors (3.4%) and 1 of 13 decedents (7.7%) in 2 of 12 studies were positive for viral RNA in semen and testicular tissue, respectively. After stratification of patient groups, we found that the virus was detected in the relatively early stage of infection, 6–16 days after disease onset, in semen from survivors. Two of 3 studies reported that some participants had substandard semen quality after COVID‐19, and 1 study found that COVID‐19 may impair semen quality in a severity‐related manner. Pathological analyses showed that injuries to the seminiferous tubule occurred in all decedents (N = 11). Another study found that orchitic and testis fibrin microthrombi occurred in patients with fatal disease (100%, N = 2). Scrotal discomfort of orchiepididymitis or spermatic cord inflammation has also been reported in COVID‐19 patients. CONCLUSION: Current studies suggest that semen is rarely considered a carrier of SARS‐CoV‐2 genetic material during the infection period but not in the semen of recovered patients. Fatal COVID‐19 may cause testicular structure damage without the presence of virus. Since the first case of coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was reported in Wuhan, China, it has rapidly spread and affected more than 21 million people worldwide as of 17 August 2020. 1 SARS-CoV-2 uses angiotensin-converting enzyme II (ACE2) to enter host cells, similar to SARS-CoV, which emerged 18 years ago. 2 COVID-19 induces respiratory-predominant multiorgan dysfunction, including myocardial, renal, enteric and hepatic dysfunction, which coincides with the tissue expression of ACE2. 3 Meanwhile, several studies have shown that ACE2 is expressed in human testes (eg spermatogonia, Leydig cells and Sertoli cells), 4, 5 suggesting that the testes may be another organ affected by COVID-19. Numerous viruses have been detected in human semen. 6 Viruses may persist in semen and last longer in seminal fluid than in other body fluids due to the immune privilege of the testes and the contribution of the blood-testes barrier to resistance to therapeutic agents. 7, 8 Semen may also have higher loads of viruses, such as Zika virus, than blood. 9, 10 Therefore, the testes may act as a reservoir of virus, which may cause imprecise evaluation of viral clearance in patients. Viruses, including Zika virus, Ebola virus, cytomegalovirus and human immunodeficiency virus (HIV), have been isolated from semen and can be sexually transmitted. 6, 11, 12 Furthermore, some viruses (eg HIV, Zika virus, herpes simplex virus (HSV) and human papillomavirus) can adhere to or be internalized by spermatozoa, 7,13 which may pose a risk for embryonic infection and cause adverse reproductive outcomes. On the other hand, many viruses, such as mumps virus, HIV and HSV, 7, 14 have been found to impair semen quality, and they may directly interact with spermatozoa or affect spermatogenesis by inducing local inflammation. [15] [16] [17] Previous studies found that SARS, 1 of the 3 epidemic coronaviruses to emerge in the past 20 years and that shows similar clinical presentations to COVID-19, 18 could cause orchitis 19 and focal testicular atrophy. 20 Considering the tens of millions of COVID-19 cases and that men are more vulnerable to COVID-19 than women, [21] [22] [23] it is imperative to determine the effect of COVID-19 on male reproduction. 24 Several studies have been performed on this topic. However, the results are controversial. For example, some researchers have reported that SARS-CoV-2 was not detected in the male reproductive tract, [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] while others reported that SARS-CoV-2 RNA was found in the semen or testes of COVID-19 patients. 35, 36 There are also unknown factors regarding COVID-19 and male reproduction. Orchitis and broad destruction of the testes were found in deceased COVID-19 patients, 35, 37 while the pathological characteristics in survivors remain unknown. In this review, we summarize the current research focusing on the effects of COVID-19 on male reproduction from the following 3 aspects: detection of SARS-CoV-2 in the male reproductive tract, determination of the impact of COVID-19 on sperm quality and exploration of pathological changes in the testes of COVID-19 patients. We further discuss the discrepancies and summarize the unknown topics, which we believe will be helpful for future research. A systematic search of published studies was conducted in the PubMed and Ovid Embase databases for studies published from December 2019 to 18 August 2020 in accordance with PRISMA. 38 All titles or abstracts of English-language studies were reviewed for eligibility. Citations and references of the retrieved studies were used as additional sources. There was no limitation on sample size, and case reports were included. A full-text review was performed by 2 independent reviewers (Y.Y. and X.Y.) on studies that reported the detection of SARS-CoV-2 in the male reproductive tract, determined the impact of COVID-19 on sperm quality and explored pathological changes in the testes of COVID-19 patients. Any disagreements between reviewers were discussed with a third reviewer (L.W.). The Cochrane RoB 2.0 tool was not applicable, and the Newcastle-Ottawa Scale was not used due to the limited scope of the cohort studies among the included studies. After reviewing the studies retrieved from the database, citations and references were added based on a review of the title or abstract ( Figure 1 ). Fourteen studies were eligible and were included in this study, with 12 studies detecting SARS-CoV-2 in the male reproductive tract, 3 determining the impact of COVID-19 on sperm quality and 3 exploring pathological changes in the testes of COVID-19 patients. Twelve studies investigated the presence of SARS-CoV-2 in the male reproductive tract (eg semen, prostatic secretion or testicular tissue) and are shown in Table 1 . Most studies were cross-sectional in design and included mainly Chinese subjects. In brief, ten of 12 studies reported that none of the participants had SARS-CoV-2 RNA in semen, prostatic secretion or testicular tissue, [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] and 2 studies reported that some subjects were positive for viral RNA in semen or testicular tissue. 35 ). Patients with mild illness were negative for SARS-CoV-2 RNA in semen during the infection period [28] [29] [30] [31] 33, 34 and recovered period. 26, 27 Patients with moderate illness were negative for viral RNA in semen during the infection period [29] [30] [31] 34 and recovered period. 27 Other findings include that asymptomatic subjects did not have viral RNA in semen, 26, 32, 33 that patients during the infection period who were not grouped by clinical severity did not have viral RNA in semen and prostatic secretions, 25, 27 and that a deceased patient (with a positive RNA test from a pharyngeal swab) did not have viral RNA in his testicular tissue. 26 All 7 cases (from 2 studies) who were positive for SARS-CoV-2 RNA in semen or testicular tissue were in the infection period. 35, 36 Four and 2 of the patients who were positive for viral RNA in semen were in the acute infection and clinical recovery periods, respectively, with interval times (from onset of symptoms to testing of semen) of 6-11 and 12-16 days, respectively. This was a shorter duration than most studies that reported negative viral RNA in semen 26,27,29-31 but a longer duration than 1 study that reported negative viral RNA within an interval time of 0-7 days (median: 1 day), 34 suggesting that SARS-CoV-2 may be shed into semen at a relatively early stage of COVID-19 and then cleared. However, some details of the research were not available, and therefore, its accuracy cannot be fully verified. (1) The subjects may have included severe or critical cases. The study was conducted in the only COVID-19-designated hospital in a local city, and some patients were excluded because they were comatose or dying; however, the disease severity of the participants was not provided. (2) The detection of SARS-CoV-2 in semen is also an arguable point due to lacking information on RNA extraction, amplification, limit of detection (LoD), gene target and cycle threshold (Ct). 40 (3) In addition, the sample collection procedure was not described. In another study, 1 of 12 deceased COVID-19 patients who died 30 days after the onset of disease had viral RNA in his testicular tissue and lung F I G U R E 1 Flow chart of the study identification process. Three of the above studies further investigated the semen parameters ( One study investigated the effect of COVID-19 on semen quality among recovered males. 27 Whether reduced testosterone in patients represents a pre-existing condition or virus-induced hypogonadism is unclear. It is also possible that testosterone might contribute to COVID-19 by upregulating TMPRSS2 expression and modulating coagulation. 57 Conversely, testosterone may favour resistance to COVID-19 by maintaining respiratory muscle activity and suppressing immune and inflammatory responses. 57, 58 In summary, the relationship between testosterone and COVID-19 is multifactorial and needs further research. 59 The research also reported that 3 of 12 enrolled patients experienced a loss of libido, and 1 experienced the loss of morning erections after having COVID-19. 30 It was suspected that COVID-19 might affect male sexual health. 60 However, a large-sample cross-sectional online survey found that sexual desire and sexual frequency were also decreased among the non-COVID-19 population during the pandemic, 61 suggesting that the COVID-19 pandemic and related containment measures may generally affect sexual health. Currently, the evidence is insufficient to link COVID-19 and semen Three studies investigated the pathological changes in the testes of deceased COVID-19 patients (Table 3) Ma et al. 30 12 One mild case tested positive for viral RNA 5 days before trial, and 11 moderate cases tested negative on the day of trial. Several conclusions can be drawn from these studies. First, SARS-CoV-2 was rarely present in the reproductive tract of men with mild-moderate COVID-19, and viral RNA was not present in the reproductive tract of recovered patients. Therefore, the testes may This work was supported by the National Natural Science Foundation of China [grant numbers: 81771654 and 81701520]. None. WHO. Coronavirus disease (COVID-2019) situation reports A pneumonia outbreak associated with a new coronavirus of probable bat origin SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2 The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia The Breadth of Viruses in Human Semen Viral threat to male fertility Persistence of Zika Virus in Body Fluids -Final Report Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen? Duration of the Presence of Infectious Zika Virus in Semen and Serum Molecular Evidence of Sexual Transmission of Ebola Virus Sexual transmission of Zika virus and other flaviviruses: A living systematic review Zika virus in semen and spermatozoa Viruses in the mammalian male genital tract and their effects on the reproductive system Mumps virus-induced innate immune responses in mouse Sertoli and Leydig cells Zika Virus Causes Testis Damage and Leads to Male Infertility in Mice Cytokines and chemokines in testicular inflammation: A brief review Insight into 2019 novel coronavirus -An updated interim review and lessons from SARS-CoV and MERS-CoV Orchitis: a complication of severe acute respiratory syndrome (SARS) Multiple organ infection and the pathogenesis of SARS Clinical Characteristics of Coronavirus Disease 2019 in China Clinical Characteristics of Covid-19 in New York City Why does COVID-19 kill more elderly men than women? Is there a role for testosterone? Andrology The COVID-19 pandemics: Shall we expect andrological consequences? A call for contributions to ANDROLOGY The absence of coronavirus in expressed prostatic secretion in COVID-19 patients in Wuhan city Absence of 2019 novel coronavirus in semen and testes of COVID-19 patients † Assessment of SARS-CoV-2 in human semen-a cohort study Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019 Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients Absence of SARS-CoV-2 in Semen of a COVID-19 Patient Cohort Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission Italian males recovering from mild COVID-19 show no evidence of SARS-CoV-2 in semen despite prolonged nasopharyngeal swab positivity Investigation of SARS-CoV-2 in Semen of Patients in the Acute Stage of COVID-19 Infection Pathological Findings in the Testes of COVID-19 Patients: Clinical Implications Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease Pulmonary and systemic involvement of COVID-19 assessed by ultrasound-guided minimally invasive autopsy Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement New coronavirus pneumonia prevention and control program SARS-CoV-2 presence in seminal fluid: Myth or reality SARS-CoV-2: diagnostic and design conundrums in the context of male factor infertility SARS-CoV-2 shedding and infectivity SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients Comparative study on virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients. Sci China Life Sci Detection of SARS-CoV-2 in Different Types of Clinical Specimens Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy Does SARS-CoV-2 infection cause sperm DNA fragmentation? Possible link with oxidative stress Angiotensin (1-7) and its receptor Mas are expressed in the human testis: implications for male infertility Is there an impact of the COVID-19 pandemic on male fertility? The ACE2 connection The pivotal link between ACE2 deficiency and SARS-CoV-2 infection SARS-CoV-2 infection, male fertility and sperm cryopreservation: a position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) (Societa Italiana di Andrologia e Medicina della Sessualita) Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer. Cancers (Basel) Testosterone, a key hormone in the context of COVID-19 pandemic Understanding the Complex Relationship Between Androgens and SARS-CoV2 Addressing male sexual and reproductive health in the wake of COVID-19 outbreak Impact of the COVID-19 Pandemic on Partner Relationships and Sexual and Reproductive Health: Cross-Sectional, Online Survey Study Spermatogenesis: The Commitment to Meiosis COVID-19 Autopsies Abdominal and testicular pain: An atypical presentation of COVID-19 Atypical presentation of SARS-CoV-2 infection in male genitalia Orchiepididymitis in a Boy With COVID-19 SARS-CoV-2 and Male Infertility: Possible Multifaceted Pathology Histopathologic and Autopsy Findings in Patients Diagnosed With Coronavirus Disease 2019 (COVID 19): What we know So Far Based on Correlation With Clinical, Morphologic and Pathobiological Aspects COVID-19 and male reproduction: current research and unknown factors